These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 5000254)
41. Patterns of antibiotic resistance in enterobacteriacaea colonizing hospitalised neonatal babies in Australia. Shaw EJ; Williams A; Deighton M; Cox S Arzneimittelforschung; 1971 Mar; 21(3):330-3. PubMed ID: 5205496 [No Abstract] [Full Text] [Related]
42. Amoxicillin in the treatment of infections of the lower respiratory tract. May JR; Ingold A J Infect Dis; 1974 Jun; 129(0):suppl:S189-93. PubMed ID: 4495160 [No Abstract] [Full Text] [Related]
43. Ticarcillin, carbenicillin and BL-P1908. In vitro comparison of three anti-pseudomonal semisynthetic penicillins. Fuchs PC; Thornsberry C; Barry AL; Gavan TL; Gerlach EH; Jones RN J Antibiot (Tokyo); 1977 Dec; 30(12):1098-106. PubMed ID: 599083 [No Abstract] [Full Text] [Related]
45. [Sensitivity to mezlocillin Gram-negative aerobic bacilli according to their pattern of resistance to the usual beta-lactam antibiotics (author's transl)]. Witchitz JL; Faurisson F; Christol D Nouv Presse Med; 1982 Feb; 11(5 Pt 2):314-7. PubMed ID: 6460966 [TBL] [Abstract][Full Text] [Related]
46. Comparison between carbenicillin and a -carboxyl-3-thienylmethyl penicillin (BRL 2288), a new semisynthetic penicillin active against Pseudomonas aeruginosa. Klastersky J; Daneau D Curr Ther Res Clin Exp; 1972 Aug; 14(8):503-9. PubMed ID: 4629312 [No Abstract] [Full Text] [Related]
47. Clinical trial of piperacillin with acquisition of resistance by Pseudomonas and clinical relapse. Simon GL; Snydman DR; Tally FP; Gorbach SL Antimicrob Agents Chemother; 1980 Jul; 18(1):167-70. PubMed ID: 6448020 [TBL] [Abstract][Full Text] [Related]
49. [Bacterial flora and its sensitivity to antibiotics in urinary tract infections in children]. Szozda G; Nowakowska K Probl Med Wieku Rozwoj; 1984; 13():59-67. PubMed ID: 6442420 [TBL] [Abstract][Full Text] [Related]
50. [Carbenicillin and gentamycin. In vitro investigations of 2 broad-spectrum antibiotics active against Pseudomonas aeruginosa]. Rosdahl N; Thomsen VF Ugeskr Laeger; 1971 Sep; 133(37):1817-22. PubMed ID: 5001170 [No Abstract] [Full Text] [Related]
51. Advances in antibiotics. Eykyn SJ; Phillips I Practitioner; 1969 Oct; 203(216):501-9. PubMed ID: 4901134 [No Abstract] [Full Text] [Related]
52. [Comparative activity of cefsulodin on Pseudomonas aeruginosa, Acinetobacter and Enterobacteriaceae (author's transl)]. Courtieu AL; Drugeon HB; Bryskier A; Chung SS; Reynaud A Pathol Biol (Paris); 1982 Jun; 30(6):432-9. PubMed ID: 6810287 [TBL] [Abstract][Full Text] [Related]
54. Evaluation of an indanyl ester of carbenicillin. Wallace JF; Atlas E; Bear DM; Brown NK; Clark H; Turck M Antimicrob Agents Chemother (Bethesda); 1970; 10():223-6. PubMed ID: 5521341 [No Abstract] [Full Text] [Related]
55. In vitro antimicrobial activity of 6(D(-) -amino-p-hydroxyphenylacetamido) penicillanic acid, a new semisynthetic penicillin. Neu HC; Winshell EB Antimicrob Agents Chemother (Bethesda); 1970; 10():407-10. PubMed ID: 4398823 [No Abstract] [Full Text] [Related]
56. [In-vitro activity of cefotaxime]. Knothe H Wien Klin Wochenschr Suppl; 1983; 142():4-7. PubMed ID: 6316671 [TBL] [Abstract][Full Text] [Related]
57. [Enterobacteriaceae isolated in eastern Romania: the evolution of ampicillin sensitivity in the 1970-1995 period]. Poiata A; Gheorghiu R; Constantiniu S; Debita M; Tiron G; Buiuc D Bacteriol Virusol Parazitol Epidemiol; 1997; 42(1-2):21-6. PubMed ID: 9235138 [TBL] [Abstract][Full Text] [Related]
58. Ampicillin and cephalothin susceptibility of community-acquired Enterobacteriaceae. Klingman K; Mylotte JM N Y State J Med; 1982 Dec; 82(13):1801-4. PubMed ID: 6961301 [No Abstract] [Full Text] [Related]